Real-World One-Year Data on the Use of Bempedoic Acid in Patients With Dyslipidemia: Insights From the Milos Austria Study | Synapse

⌘+K

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Role of Neutrophil Extracellular Traps in AtherosclerosisAtherosclerosis · 2026
2Prognostic Value of 13N-Ammonia PET–Derived Myocardial Flow Reserve and Its Association With Peripheral Arterial Flow Impairment and Aortic Stiffness in Hemodialysis PatientsAtherosclerosis · 2026
3Circulating NOX2 and risk of cardiovascular events in the general population: results from the Moli-sani studyAtherosclerosis · 2026
4Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studiesAtherosclerosis · 2024
5Resistant Arterial Hypertension Within a Constellation of ComorbiditiesAtherosclerosis · 2026

Utilising Bempedoic Acid for Secondary Ascvd Prevention in a Rural Primary Care Practice: Real-World LDL-C Outcomes, Adherence, and Clinician Strategies Supporting Treatment PersistenceAtherosclerosis · 2026
Preferred Secondary Prevention LDL-C Targets by Uk Healthcare Professionals – Nice vs Esc: Insights From the Primary Care Cardiovascular Society, UkAtherosclerosis · 2026
Mixed-Methods Analysis of Patient Understanding of Icosapent Ethyl and Ascvd Risk in Rural Primary CareAtherosclerosis · 2026
The Triglyceride-Glucose Index as a Predictive Marker for Inadequate Glycemic Control, and Self-Management Assessed With Diabetes Self-Management Questionnaire-Revised in Type 2 Diabetes PatientsAtherosclerosis · 2026
Renal Function in Angptl3 Deficiency: Evidence From an Observational Human StudyAtherosclerosis · 2026

More from Atherosclerosis

More from Imperial College London